These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 16289160

  • 1. The pharmacokinetics of rituximab following an intravitreal injection.
    Kim H, Csaky KG, Chan CC, Bungay PM, Lutz RJ, Dedrick RL, Yuan P, Rosenberg J, Grillo-Lopez AJ, Wilson WH, Robinson MR.
    Exp Eye Res; 2006 May; 82(5):760-6. PubMed ID: 16289160
    [Abstract] [Full Text] [Related]

  • 2. Clearance of intravitreal voriconazole.
    Shen YC, Wang MY, Wang CY, Tsai TC, Tsai HY, Lee YF, Wei LC.
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2238-41. PubMed ID: 17460285
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of intravitreal bevacizumab (Avastin).
    Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ.
    Ophthalmology; 2007 May; 114(5):855-9. PubMed ID: 17467524
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of intravitreal ranibizumab (Lucentis).
    Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ.
    Ophthalmology; 2007 Dec; 114(12):2179-82. PubMed ID: 18054637
    [Abstract] [Full Text] [Related]

  • 5. Intraocular use of rituximab.
    Kitzmann AS, Pulido JS, Mohney BG, Baratz KH, Grube T, Marler RJ, Donaldson MJ, O'Neill BP, Johnston PB, Johnson KM, Dixon LE, Salomao DR, Cameron JD.
    Eye (Lond); 2007 Dec; 21(12):1524-7. PubMed ID: 17464308
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E, Berdugo M, Stella C, Behar-Cohen F, Gurny R, Feige U, Lichtlen P, Urech DM.
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [Abstract] [Full Text] [Related]

  • 7. Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
    Ottiger M, Thiel MA, Feige U, Lichtlen P, Urech DM.
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):779-86. PubMed ID: 18757511
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits.
    Gaudreault J, Fei D, Beyer JC, Ryan A, Rangell L, Shiu V, Damico LA.
    Retina; 2007 Feb; 27(9):1260-6. PubMed ID: 18046235
    [Abstract] [Full Text] [Related]

  • 9. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration.
    Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V.
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):726-33. PubMed ID: 15671306
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment.
    Buitrago E, Höcht C, Chantada G, Fandiño A, Navo E, Abramson DH, Schaiquevich P, Bramuglia GF.
    Exp Eye Res; 2010 Jul; 91(1):9-14. PubMed ID: 20307538
    [Abstract] [Full Text] [Related]

  • 11. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA, Cej A, Jonas JB.
    Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
    [Abstract] [Full Text] [Related]

  • 12. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique.
    Macha S, Mitra AK.
    Exp Eye Res; 2001 Mar; 72(3):289-99. PubMed ID: 11180978
    [Abstract] [Full Text] [Related]

  • 13. Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.
    Mineo JF, Scheffer A, Karkoutly C, Nouvel L, Kerdraon O, Trauet J, Bordron A, Dessaint JP, Labalette M, Berthou C, Labalette P.
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4738-45. PubMed ID: 18552383
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution.
    Kane A, Barza M, Baum J.
    Invest Ophthalmol Vis Sci; 1981 May; 20(5):593-7. PubMed ID: 6971281
    [Abstract] [Full Text] [Related]

  • 15. Clearance of intravitreal moxifloxacin.
    Iyer MN, He F, Wensel TG, Mieler WF, Benz MS, Holz ER.
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):317-9. PubMed ID: 16384979
    [Abstract] [Full Text] [Related]

  • 16. The ocular hypotensive effects of demeclocycline, tetracycline and other tetracycline derivatives.
    Wallace I, Krupin T, Stone RA, Moolchandani J.
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1594-8. PubMed ID: 2501230
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of the antineoplastic agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in the aqueous and vitreous of rabbit.
    Ueno N, Refojo MF, Liu LH.
    Invest Ophthalmol Vis Sci; 1982 Aug; 23(2):199-208. PubMed ID: 7096015
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of intravitreal carbenicillin, cefazolin, and gentamicin in rhesus monkeys.
    Barza M, Kane A, Baum J.
    Invest Ophthalmol Vis Sci; 1983 Dec; 24(12):1602-6. PubMed ID: 6654640
    [Abstract] [Full Text] [Related]

  • 19. Effect of intracameral and intravitreal injection of calcitonin gene-related peptide on the intraocular pressure and outflow facility of aqueous humor in the rabbit.
    Oksala O, Heino P, Uusitalo H, Palkama A.
    Exp Eye Res; 1998 Oct; 67(4):411-5. PubMed ID: 9820788
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-10 and interleukin-6 in aqueous humor during treatment of vitreoretinal lymphoma with intravitreally injected methotrexate.
    Kawamura H, Yasuda N, Kakinoki M, Sawada T, Sawada O, Ohji M.
    Ophthalmic Res; 2009 Oct; 42(3):172-4. PubMed ID: 19648778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.